Getting Medicare to cover Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
admin An experimental Alzheimer’s disease treatment developed by Eisai and Biogen that appears to slow cognitive…
Read MoreCredit
Fannie Mae launches pilot program to include on-time rent payments in credit reports. Here’s why this could be a game changer for renters.
When tenants pay their rent on time, it largely fails to improve their credit scores,…
Read MoreMortgage applications fall and adjustable-rate mortgages make a comeback
The numbers: After a brief uptick, mortgage applications resume their downward spiral as home buyers…
Read MoreUK Government Tax Cuts Are Credit Negative, Moody’s Says
By Xavier Fontdegloria The series of large tax cuts and increased spending outlined by the…
Read MoreMy daughter died from a drug overdose, and two of her kids were raised by their other grandparents. I’m leaving my house to my son’s child. Is that fair?
My husband recently died and I am in the process of getting the financial paperwork…
Read MoreRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreEisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreChina’s offshore yuan falls to record low against U.S. dollar
China’s currency hit its weakest ever offshore trading level against the U.S. dollar, with the…
Read MoreAlzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read More
Here’s why one strategist says the consumer and related stocks might get a second wind
Welcome to intervention Wednesday. The Bank of England has halted, at least for now, soaring…
Read More